株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

クラミジア感染症:世界の治験レビュー

Chlamydia Infections Global Clinical Trials Review, H2, 2018

発行 GlobalData 商品コード 177202
出版日 ページ情報 英文 84 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.28円で換算しております。
Back to Top
クラミジア感染症:世界の治験レビュー Chlamydia Infections Global Clinical Trials Review, H2, 2018
出版日: 2018年12月31日 ページ情報: 英文 84 Pages
概要

クラミジアは、非常に小さな細菌、クラミジア・トラコマチスによって引き起こされる性感染症(STI)です。頸部、尿道、卵管、子宮、鼻咽頭、副睾丸に影響を与えます。

当レポートでは、クラミジア感染症の治療薬に関する治験について調査分析し、治験数および被験者数、段階別・相別の状況、有望企業、開発中の治療薬の情報、治験プロファイルなどについて、体系的な情報を提供しています。

目次

イントロダクション

地域別の治験

  • 国別の治験動向
    • アジア太平洋地域の主要国
    • 欧州の主要国
    • 北米の主要国
    • 中東・アフリカの主要国
    • 中南米の主要国

G7諸国における治験:感染性疾患の治験に対するクラミジア感染症の割合

G7諸国における治験:相別

G7諸国における治験:段階別

E7諸国における治験:感染性疾患の治験に対するクラミジア感染症の割合

E7諸国における治験:相別

E7諸国における治験:段階別

相別の治験

段階別の治験

評価項目別の治験

未完了の治験

一定期間に採用された被験者

スポンサータイプ別の治験

有望なスポンサー

  • クラミジア感染症の治療薬の治験に参加している主要企業

有望薬

治験プロファイル

  • 主要企業の治験概要
    • キョーリン製薬ホールディングス
    • Endo International plc
    • Cempra Pharmaceuticals, Inc.
    • ActivBiotics Pharma, LLC
    • Actavis plc
  • 主要大学・研究機関・病院の治験概要
    • University of California, San Francisco
    • Johns Hopkins University
    • Centers for Disease Control and Prevention
    • National Heart, Lung, and Blood Institute
    • University of Pittsburgh
    • The University of Melbourne
    • Washington University School of Medicine
    • London School of Hygiene & Tropical Medicine
    • Population Council
    • Barts and The London NHS Trust

主な臨床プロファイル

付録

図表

図表

List of Tables

  • Chlamydia Infections Therapeutics, Global, Clinical Trials by Region, 2018* 7
  • Chlamydia Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
  • Chlamydia Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Chlamydia Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
  • Chlamydia Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
  • Chlamydia Infections Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
  • Chlamydia Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
  • Chlamydia Infections Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15
  • Proportion of Chlamydia Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 16
  • Chlamydia Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
  • Chlamydia Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
  • Proportion of Chlamydia Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 20
  • Chlamydia Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
  • Chlamydia Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
  • Chlamydia Infections Therapeutics, Global, Clinical Trials by Phase, 2018* 23
  • Chlamydia Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 24
  • Chlamydia Infections Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25
  • Chlamydia Infections Therapeutics Clinical Trials, Global, by End Point Status, 2018* 26
  • Chlamydia Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 27
  • Chlamydia Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 28
  • Chlamydia Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30
  • Chlamydia Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32
  • Chlamydia Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 33

List of Figures

  • Chlamydia Infections Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
  • Chlamydia Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Chlamydia Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Chlamydia Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
  • Chlamydia Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
  • Chlamydia Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
  • Proportion of Chlamydia Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 16
  • Chlamydia Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
  • Chlamydia Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
  • Proportion of Chlamydia Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 19
  • Chlamydia Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
  • Chlamydia Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
  • Chlamydia Infections Therapeutics, Global, Clinical Trials by Phase (%), 2018* 23
  • Chlamydia Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 24
  • Chlamydia Infections Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25
  • Chlamydia Infections Therapeutics Clinical Trials, Global, by End Point Status, 2018* 26
  • Chlamydia Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 27
  • Chlamydia Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 28
  • Chlamydia Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 29
  • Chlamydia Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 31
  • Chlamydia Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 33
  • GlobalData Methodology 83
目次
Product Code: GDHC5551CTIDB

GlobalData's clinical trial report, "Chlamydia Infections Global Clinical Trials Review, H2, 2018" provides an overview of Chlamydia Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Chlamydia Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • Table of Contents 2
    • List of Tables 3
    • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
    • Clinical Trials and Average Enrollment by Country 8
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
      • Top Five Countries Contributing to Clinical Trials in Europe 12
      • Top Countries Contributing to Clinical Trials in North America 13
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
      • Top Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Chlamydia Infections to Infectious Disease Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Chlamydia Infections to Infectious Disease Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 21
  • Clinical Trials in E7 Countries by Trial Status 22
  • Clinical Trials by Phase 23
    • In Progress Trials by Phase 24
  • Clinical Trials by Trial Status 25
  • Clinical Trials by End Point Status 26
  • Subjects Recruited Over a Period of Time 27
  • Clinical Trials by Sponsor Type 28
  • Prominent Sponsors 29
    • Top Companies Participating in Chlamydia Infections Therapeutics Clinical Trials 31
  • Prominent Drugs 33
  • Clinical Trial Profile Snapshots 34
  • Appendix 82
    • Abbreviations 82
    • Definitions 82
    • Research Methodology 83
    • Secondary Research 83
    • About GlobalData 84
    • Contact Us 84
  • Source 84
Back to Top